Emodin Sensitizes Hepatocellular Carcinoma Cells to the Anti-Cancer Effect of Sorafenib through Suppression of Cholesterol Metabolism

Reduced therapeutic efficacy of sorafenib, a first-generation multikinase inhibitor, is often observed during the treatment of advanced hepatocellular carcinoma (HCC). Emodin is an active component of Chinese herbs, and is effective against leukemia, lung cancer, colon cancer, pancreatic cancer, and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Kim, Young-Seon, Lee, Yoon-Mi, Oh, Taek-In, Shin, Dong Hoon, Kim, Geon-Hee, Kan, Sang-Yeon, Kang, Hyeji, Kim, Ji Hyung, Kim, Byeong Mo, Yim, Woo Jong, Lim, Ji-Hong
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6213641/
https://ncbi.nlm.nih.gov/pubmed/30321984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19103127
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados